T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Enovis
ENOV
$1.48B
| $431M | 0.06% |
6,947,208
+6,637
| +0.1% | +$378K |
|
302
IQVIA
IQV
$39.8B
| $430M | 0.06% |
3,311,357
-495,546
| -13% | -$59.5M |
|
303
WIX.com
WIX
$3.35B
| $426M | 0.06% |
3,559,324
-977,528
| -22% | -$105M |
|
304
SLB Ltd
SLB
$77.3B
| $423M | 0.06% |
6,943,044
+306,865
| +5% | +$19.8M |
|
|
THS
305
DELISTED
Treehouse Foods
THS
| $418M | 0.06% |
8,743,512
+135,450
| +2% | +$6.96M |
|
306
RTX Corp
RTX
$297B
| $418M | 0.06% |
4,748,626
-109,362
| -2% | -$9.18M |
|
307
CMS Energy
CMS
$22.1B
| $413M | 0.06% |
8,421,289
-16,588
| -0.2% | -$809K |
|
308
FirstService
FSV
$6.18B
| $412M | 0.06% |
4,862,838
+151,006
| +3% | +$12.5M |
|
309
Ulta Beauty
ULTA
$22.2B
| $410M | 0.06% |
1,454,046
-113,763
| -7% | -$29M |
|
310
AbbVie
ABBV
$443B
| $409M | 0.06% |
4,326,215
-848,371
| -16% | -$80.5M |
|
311
Mondelez International
MDLZ
$81.1B
| $405M | 0.06% |
9,430,404
-1,197,920
| -11% | -$51.1M |
|
312
KeyCorp
KEY
$24.6B
| $403M | 0.06% |
20,250,895
-3,574,334
| -15% | -$74.2M |
|
313
Canadian Pacific Kansas City
CP
$82.6B
| $403M | 0.06% |
9,508,625
-1,127,465
| -11% | -$45.1M |
|
314
T-Mobile US
TMUS
$197B
| $401M | 0.06% |
5,715,609
-87,319
| -2% | -$5.61M |
|
315
MarketAxess Holdings
MKTX
$5.72B
| $399M | 0.06% |
2,235,581
-50,267
| -2% | -$9.66M |
|
|
SRCL
316
DELISTED
Stericycle Inc
SRCL
| $397M | 0.06% |
6,767,227
+528,775
| +8% | +$33.8M |
|
317
Align Technology
ALGN
$12.5B
| $396M | 0.06% |
1,012,682
-80,085
| -7% | -$29.5M |
|
318
Boston Beer
SAM
$1.9B
| $394M | 0.06% |
1,370,182
+339,939
| +33% | +$102M |
|
319
QuidelOrtho
QDEL
$1.03B
| $393M | 0.06% |
6,037,851
-59,844
| -1% | -$4.18M |
|
320
Western Alliance Bancorporation
WAL
$8.92B
| $393M | 0.06% |
6,909,728
-10,603
| -0.2% | -$611K |
|
321
Republic Services
RSG
$65.9B
| $393M | 0.06% |
5,409,673
-2,950,073
| -35% | -$214M |
|
322
Pediatrix Medical
MD
$2.14B
| $393M | 0.06% |
8,422,948
-137,732
| -2% | -$6.32M |
|
323
Descartes Systems
DSGX
$6.62B
| $389M | 0.06% |
11,477,725
-21,549
| -0.2% | -$728K |
|
324
Illumina
ILMN
$29.1B
| $388M | 0.06% |
1,087,675
-800,403
| -42% | -$256M |
|
|
BLUE
325
DELISTED
bluebird bio
BLUE
| $388M | 0.06% |
205,118
-12,979
| -6% | -$26.8M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.